New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
10:15 EDTLGCY, PRGO, WU, ACAD, DVA, FURX, YOKU, AKRXOn The Fly: Analyst Initiation SummaryWestern Union
Today's noteworthy initiations include: Akorn (AKRX) initiated with a Sector Perform at RBC Capital... DaVita (DVA) initiated with a Market Perform at Bernstein... Perrigo (PRGO) initiated with a Sector Perform at RBC Capital... Youku Tudou (YOKU) initiated with a Buy at Deutsche Bank... ACADIA (ACAD) initiated with an Outperform at Cowen... Furiex (FURX) initiated with a Buy at Canaccord... Legacy Reserves (LGCY) initiated with a Buy at Ladenburg... PBF Energy (WU) initiated with a Buy at Dahlman Rose.
News For AKRX;DVA;PRGO;YOKU;ACAD;LGCY;FURX;WU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2015
10:00 EDTYOKUOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:17 EDTYOKUYouku Tudou upgraded to Neutral from Underweight at HSBC
Subscribe for More Information
08:14 EDTWUWestern Union extends USSC agent agreement in the Philippines
Subscribe for More Information
January 28, 2015
08:08 EDTPRGOGalmed and Perrigo sign agreement for aramchol API production
Galmed (GLMD) has entered into a Manufacturing Services Agreement with Perrigo (PRGO) subsidiary Perrigo API Ltd. for the large-scale production of the active pharmaceutical ingredient of Galmed's product candidate, aramchol. The API produced pursuant to this agreement is expected to provide sufficient quantities of aramchol for Galmed's potential future Phase III clinical trials of aramchol for the treatment of Non-Alcoholic Steato-Hepatitis, or NASH. The agreement also provides Perrigo with the option to manufacture commercial supplies of the aramchol API in the future.
07:19 EDTACADACADIA price target raised to $50 from $42 at Jefferies
Jefferies raised its price target for ACADIA shares to $50 after increasing its Nuplazid sales estimates in Parkinson's disease psychosis. The firm believes Nuplazidís efficacy and safety profile could lead to a strong launch and keeps a Buy rating on ACADIA.
January 27, 2015
17:51 EDTAKRXS&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices
Subscribe for More Information
17:22 EDTAKRXUnited Insurance to replace Akorn in S&P 600 as of 1/30 close
17:21 EDTAKRXAkorn to replace Protective Life in S&P 400 as of 1/30 close
Subscribe for More Information
08:03 EDTWUWestern Union to offer Apple Pay at flagship locations
Western Union (WU) announced it will offer Apple (AAPL)ís technology Apple Pay mobile payment solution at Western Unionís flagship locations, to provide consumers yet another way to fund global money transfers and bill payments in the United States. Consumers making Western Union transactions at kiosks in over 7,600 Walgreens and Duane Reade locations nationwide also have the ability to utilize the Apple Pay service.
January 26, 2015
07:05 EDTAKRXAkorn price target raised to $55 from $45 at Piper Jaffray
Piper Jaffray raised its price target for Akorn shares to $55 saying approvals of "seemingly minor" abbreviated New Drug Application opportunities, like last week's Phenylephrine Hydrochloride Ophthalmic Solution, could in the aggregate drive significant upside to consensus estimates in 2015 and beyond. Piper reiterates an Overweight rating on shares of Akorn.
January 22, 2015
10:03 EDTLGCYOn the Fly: Analyst Downgrade Summary
Subscribe for More Information
06:32 EDTLGCYLegacy Reserves downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
January 20, 2015
11:16 EDTPRGOPerrigo management to meet with B. Riley
Subscribe for More Information
08:09 EDTAKRXAkorn price target raised to $49 from $44 at Jefferies
Jefferies raised its price target for Akorn shares to $49 to reflect its FY15 estimates. The firm keeps a Buy rating on the stock.
07:28 EDTWUTreasury Institute for Higher Education to hold a symposium
Subscribe for More Information
07:11 EDTAKRXAkorn receives FDA approval for Phenylephrine Hydrochloride Ophthalmic Solution
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use